DUC: Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks

Sponsor
Mount Sinai Hospital, Canada (Other)
Overall Status
Unknown status
CT.gov ID
NCT00562536
Collaborator
(none)
296
1
2
36
8.2

Study Details

Study Description

Brief Summary

The overall objective of the present study is to examine the effects of delayed umbilical cord clamping in preterm infants on neonatal outcomes using a prospective randomized controlled trial comparing immediate cord clamping (standard at present) with delayed cord clamping.

Our specific aim is to determine if a 30 to 45 second delay in umbilical cord clamping improves neonatal outcome as assessed by a composite of intraventricular hemorrhage and late onset sepsis in preterm infants born between 24 and 32 weeks gestation. Secondary outcomes to be examined include improvements in the following: 1) lung function as assessed by oxygen dependency at 36 weeks corrected gestational age (CGA), 2) cardiovascular function as assessed by the need for volume expansion, inotropes, or clinically suspected PDA requiring intervention prior to discharge home, and 3) anemia as assessed by initial hemoglobin, need for transfusion during stay in the NICU, and number of transfusions.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Umbilical cord clamping
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
296 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Delayed Umbilical Cord Clamping in Infants Less Than 32 Weeks: A Randomized Controlled Trial
Study Start Date :
Nov 1, 2007
Anticipated Study Completion Date :
Nov 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: A 1

Delayed umbilical cord clamping 30-45 seconds.

Procedure: Umbilical cord clamping
Delay of umbilical cord clamping 30 to 45 seconds

No Intervention: A 2

Immediate umbilibcal cord clamping

Outcome Measures

Primary Outcome Measures

  1. Primary Composite outcome of Intraventricular Hemorrhage and/or Late Onset Sepsis [3 years]

Secondary Outcome Measures

  1. Secondary outcomes include: 1) lung function 2) cardiovascular function and 3) anemia. [3 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women in labour or with a plan for delivery at a gestational age between 24 0/7 to 32 0/7 weeks gestation.

  • Singleton pregnancy (Note: if pregnancy was a multiple gestation but demised occurred prior to 13 weeks, these patients can be included in study).

Exclusion Criteria:
  • Moderate to life threatening fetal anomalies

  • Multiple live gestations at birth (e.g. twins, triplets, etc)

  • Intrauterine fetal demise

  • Previous participation

  • Stem cell collection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Sinai Hospital Toronto Ontario Canada M5G 1X5

Sponsors and Collaborators

  • Mount Sinai Hospital, Canada

Investigators

  • Principal Investigator: Kellie E Murphy, MD MSc, Mount Sinai Hospital, Canada

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00562536
Other Study ID Numbers:
  • Mount Sinai Hospital Toronto
First Posted:
Nov 22, 2007
Last Update Posted:
Nov 22, 2007
Last Verified:
Nov 1, 2007

Study Results

No Results Posted as of Nov 22, 2007